Johnson & Johnson
NYSE: JNJ
$172.20
+$0.02 (+0.0%)
Closing price July 30, 2021
Three Dow Jones industrial average components are reporting June-quarter results before markets open Wednesday.
12 days ago
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
1 month ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Dollar General, Johnson & Johnson, HP and Teladoc.
2 months ago
Earnings season hits its stride next week and here are previews of four companies reporting March quarter results early Tuesday.
3 months ago
Last Updated: 3 months ago
Johnson & Johnson officially enters the fight against COVID-19 as its single-shot vaccine was approved over the weekend. It plans to deliver 100 million single-shot vaccines during the first half of...
4 months ago
These five BofA Securities high-quality stock picks have good prospects for the rest of 2021 and should continue to be accompanied by dependable dividends. They may be an alternative for conservative...
5 months ago
24/7 Wall St. has put together a preview of those Dow companies scheduled to report their quarterly results this week, including Apple, Boeing, Microsoft and Verizon.
6 months ago
While positive earnings could continue to drive the major indexes higher in 2021, a very overbought and fully valued market could offer some painful January indigestion. These five stocks look like...
7 months ago
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
7 months ago
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
8 months ago
Last Updated: 8 months ago
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
9 months ago
Johnson & Johnson released better than expected quarterly results before the markets opened on Tuesday, but it also announced a pause in its late-stage coronavirus vaccine trial.
9 months ago
A new earnings reporting season kicks off this week, with the big banks and a few other companies leading the way. These results will be an important barometer for what comes next.
9 months ago
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
9 months ago
These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that won't also have huge product lines and robust pipelines with future drug potential and...
10 months ago